Nuveen Asset Management’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-146,326
| Closed | -$277K | – | 3353 |
|
|
2024
Q1 | $277K | Sell |
146,326
-45,210
| -24% | -$85.4K | ﹤0.01% | 3119 |
|
|
2023
Q4 | $506K | Hold |
191,536
| – | – | ﹤0.01% | 2996 |
|
|
2023
Q3 | $441K | Buy |
191,536
+45,210
| +31% | +$104K | ﹤0.01% | 2884 |
|
|
2023
Q2 | $534K | Buy |
+146,326
| New | +$534K | ﹤0.01% | 2892 |
|
|
2022
Q2 | – | Sell |
-117,327
| Closed | -$659K | – | 3272 |
|
|
2022
Q1 | $659K | Buy |
117,327
+34,006
| +41% | +$191K | ﹤0.01% | 2934 |
|
|
2021
Q4 | $868K | Sell |
83,321
-11,222
| -12% | -$117K | ﹤0.01% | 2901 |
|
|
2021
Q3 | $1.22M | Sell |
94,543
-1,702
| -2% | -$22K | ﹤0.01% | 2915 |
|
|
2021
Q2 | $1.12M | Sell |
96,245
-6,424
| -6% | -$74.8K | ﹤0.01% | 2967 |
|
|
2021
Q1 | $1.25M | Sell |
102,669
-39,692
| -28% | -$484K | ﹤0.01% | 2818 |
|
|
2020
Q4 | $1.78M | Buy |
142,361
+911
| +0.6% | +$11.4K | ﹤0.01% | 2567 |
|
|
2020
Q3 | $2.13M | Sell |
141,450
-3,388
| -2% | -$51K | ﹤0.01% | 2351 |
|
|
2020
Q2 | $3.55M | Buy |
144,838
+58,279
| +67% | +$1.43M | ﹤0.01% | 2079 |
|
|
2020
Q1 | $1.23M | Sell |
86,559
-44,220
| -34% | -$627K | ﹤0.01% | 2417 |
|
|
2019
Q4 | $2.08M | Buy |
130,779
+60,825
| +87% | +$966K | ﹤0.01% | 2405 |
|
|
2019
Q3 | $590K | Buy |
69,954
+6,605
| +10% | +$55.7K | ﹤0.01% | 2890 |
|
|
2019
Q2 | $570K | Buy |
+63,349
| New | +$570K | ﹤0.01% | 2954 |
|